SRYSATA
DEAD

Serial Number

79335705

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jan 27, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SRYSATA Trademark

Serial Number: 79335705 • Registration: 6805718

SRYSATA is a trademark filed by NOVARTIS AG on January 27, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

January 27, 2022

Registration Date

August 2, 2022

Published for Opposition

May 17, 2022

Cancellation Date

October 2, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jul 8, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jul 8, 2025 DETH
NOTIFICATION PROCESSED BY IB
Oct 9, 2022 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Sep 15, 2022 FICS
FINAL DISPOSITION PROCESSED
Sep 15, 2022 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Sep 1, 2022 GPAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 2, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 2, 2022 R.PR
NOTIFICATION PROCESSED BY IB
May 23, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 17, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 17, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 27, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 27, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 27, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 14, 2022 PREV
ASSIGNED TO LIE
Apr 13, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 12, 2022 CNSA
ASSIGNED TO EXAMINER
Apr 11, 2022 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 6, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 6, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 6, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 6, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 6, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 6, 2022 COAR
APPLICATION FILING RECEIPT MAILED
Mar 29, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 24, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 23, 2022 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Mar 10, 2022 SDRC